Shares of Evolent Health Inc. (NYSE:EVH) were up 4.9% on Wednesday . The stock traded as high as $24.91 and last traded at $24.69, with a volume of 84,677 shares traded. The stock had previously closed at $23.53.

Several analysts have recently weighed in on EVH shares. Jefferies Group started coverage on Evolent Health in a report on Tuesday, July 26th. They set a “buy” rating and a $28.00 price objective on the stock. Leerink Swann reissued a “buy” rating and set a $20.00 price objective on shares of Evolent Health in a report on Monday, May 16th. FBR & Co reissued a “buy” rating on shares of Evolent Health in a report on Saturday, May 14th. Canaccord Genuity reissued a “buy” rating on shares of Evolent Health in a report on Friday, May 13th. Finally, Zacks Investment Research raised Evolent Health from a “sell” rating to a “hold” rating in a report on Wednesday, May 18th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Evolent Health currently has a consensus rating of “Buy” and an average price target of $22.17.

The company’s 50 day moving average is $20.28 and its 200 day moving average is $13.70. The company has a market cap of $1.45 billion and a price-to-earnings ratio of 6.45.

Evolent Health (NYSE:EVH) last released its earnings results on Thursday, May 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.03. The company had revenue of $49.50 million for the quarter, compared to the consensus estimate of $47.40 million. The company’s revenue was up 33.8% compared to the same quarter last year. On average, equities research analysts forecast that Evolent Health Inc. will post ($0.62) earnings per share for the current year.

A hedge fund recently raised its stake in Evolent Health stock. Schroder Investment Management Group raised its stake in shares of Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned approximately 0.60% of Evolent Health worth $4,310,000 as of its most recent SEC filing.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.